We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.14B
1-Year Est. Return
15.99%
This Fund
S&P 500
This Quarter
Est. Return
+1.6%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$1.39B
AUM Growth
-$490M
(-26%)
Cap. Flow
-$509M
Cap. Flow
% of AUM
-36.51%
Top 10 Holdings %
Top 10 Hldgs %
50.03%
Holding
34
New
2
Increased
10
Reduced
21
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$68.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$2.67M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$2.37M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$2.35M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$1.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$91.8M |
| 2 |
Biogen
BIIB
|
+$47.8M |
| 3 |
Apple
AAPL
|
+$37M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$33.5M |
| 5 |
PayPal
PYPL
|
+$32.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.66% |
| 2 | Consumer Staples | 19.07% |
| 3 | Communication Services | 14.69% |
| 4 | Technology | 10.27% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Adobe
ADBE
$94.3B
| $74.3M | 5.33% |
684,416
-286,449
| -30% | -$28.7M |
|
|
2
Biogen
BIIB
$30.4B
| $70.6M | 5.07% |
225,669
-161,242
| -42% | -$47.8M |
|
3
UnitedHealth
UNH
$387B
| $70M | 5.02% |
500,317
-171,139
| -25% | -$24M |
|
|
4
PayPal
PYPL
$49.9B
| $69.8M | 5% |
1,702,962
-840,652
| -33% | -$32.3M |
|
5
Mastercard
MA
$480B
| $69.4M | 4.98% |
682,268
-317,831
| -32% | -$30.5M |
|
|
6
Apple
AAPL
$4.9T
| $69M | 4.95% |
2,439,760
-1,396,656
| -36% | -$37M |
|
7
Kraft Heinz
KHC
$30.7B
| $68.8M | 4.94% |
769,166
-330,882
| -30% | -$29.3M |
|
|
8
Alphabet (Google) Class A
GOOGL
$4.23T
| $68.7M | 4.93% |
1,709,780
-856,940
| -33% | -$33.5M |
|
9
Comcast
CMCSA
$85B
| $68.4M | 4.91% |
2,062,260
-903,620
| -30% | -$30.1M |
|
10
Gilead Sciences
GILD
$167B
| $68.3M | 4.9% |
863,816
-254,584
| -23% | -$20.7M |
|
11
TJX Companies
TJX
$171B
| $68.2M | 4.89% |
1,823,726
-640,330
| -26% | -$25.1M |
|
12
Estee Lauder
EL
$29.7B
| $68.2M | 4.89% |
769,740
-253,735
| -25% | -$23.1M |
|
|
13
Medtronic
MDT
$106B
| $67.9M | 4.87% |
+786,412
| New | +$68.5M |
|
14
Walt Disney
DIS
$170B
| $67.6M | 4.85% |
728,502
-223,732
| -23% | -$21.4M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $66.9M | 4.8% |
640,435
-290,954
| -31% | -$31.5M |
|
16
CVS Health
CVS
$137B
| $66.6M | 4.78% |
748,529
-225,818
| -23% | -$21.3M |
|
17
Bristol-Myers Squibb
BMY
$124B
| $65.1M | 4.67% |
1,207,072
-83,973
| -7% | -$5.39M |
|
18
Dollar Tree
DLTR
$24.2B
| $64.8M | 4.65% |
821,201
-182,963
| -18% | -$16.5M |
|
19
Kroger
KR
$36B
| $64M | 4.59% |
2,157,752
-446,539
| -17% | -$14.8M |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $63.3M | 4.54% |
275,028
-115,607
| -30% | -$28.3M |
|
|
21
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
| $6.05M | 0.43% |
83,964
+36,272
| +76% | +$2.67M |
|
|
22
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $5.98M | 0.43% |
131,683
+52,515
| +66% | +$2.35M |
|
|
23
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $4.43M | 0.32% |
185,592
+73,812
| +66% | +$1.72M |
|
|
24
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
| $3.7M | 0.27% |
69,974
+44,746
| +177% | +$2.37M |
|
25
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
| $3.52M | 0.25% |
87,930
+38,462
| +78% | +$1.55M |
|
Similar funds
GCM
SP
ZP
BOK
SHCM
AP
CG
BT
WestEnd Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, WestEnd Advisors held 34 positions worth $1.39B, down 26% from $1.88B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
WestEnd Advisors withdrew a net $509M in Q3 2016, reducing 21 holdings. Its largest reduction was HCA Healthcare, cutting an estimated $91.8M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 40% a quarter earlier, followed by Consumer Staples and Communication Services.
Against the trend, WestEnd Advisors opened a new position in Medtronic worth $67.9M.
- WestEnd Advisors's largest Q3 2016 buy was Medtronic: 786,412 shares worth $67.9M.
- WestEnd Advisors added most to State Street Health Care Select Sector SPDR ETF in Q3 2016, an estimated $2.67M increase.
- WestEnd Advisors's biggest Q3 2016 reduction was HCA Healthcare, cutting an estimated $91.8M.
- WestEnd Advisors's ten largest holdings make up 50% of its $1.39B portfolio in Q3 2016.
- WestEnd Advisors opened 2 new positions and closed 0 in Q3 2016.
- WestEnd Advisors's portfolio value fell 26% quarter-over-quarter to $1.39B.
Based on WestEnd Advisors's 13F filing for Q3 2016, filed 1 Nov 2016.